Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas: Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell, and non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells.
Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
The Leukemia, Lymphoma and Multiple Myeloma program at UC Davis Comprehensive Cancer Center is the largest and most comprehensive program of its kind in inland Northern California. It provides the most advanced methods of diagnosis and treatment possible, including new therapies that often aren't available at community hospitals. The physicians in our Leukemia, Lymphoma and Multiple Myeloma program have extensive experience treating both common and uncommon cancers of the blood, bone marrow and lymphatic system. This includes the more than 40 subtypes of lymphoma. Our physician-scientists are also at the forefront of research to develop and test new drugs to combat this family of cancers, ensuring that new treatments developed in the lab move quickly to the clinic for the immediate benefit of our patients.